TruAlt Bioenergy Limited (TRUALT) Fair Value & Analysis
Energy · IN · Market cap ₹40.5B
Fair value as of: Jul 3, 2026
From 14 valuation models · updated today
Share price −7.0% over the past month.
Price vs Fair Value (9 months)
9‑month range ₹320.94 – ₹534.10 · fair‑value band ₹138.56 – ₹197.69 · the ₹472.30 price screens above the ₹158.15 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
TruAlt Bioenergy Limited (TRUALT) currently trades at ₹472.30, while our model-based Fair Value estimate is ₹158.15 — implying the stock looks roughly 66.5% overvalued today. We read business quality at 29/100 (below-average quality), in the Energy sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, TruAlt Bioenergy Limited generated revenue of ₹17.3B at a net margin of 5.6%. Revenue declined 34.3% year over year. It earns a return on equity of 8.3%. Net debt stands at ₹15.6B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
TruAlt Bioenergy Limited produces and sells biofuels in India. Its products include ethanol, compressed biogas, extra neutral alcohol, and fermented organic manure. The company was formerly known as TruAlt Energy Limited and changed its name to TruAlt Bioenergy Limited in July 2022. TruAlt Bioenergy Limited was incorporated in 2021 and is based in Bengaluru, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
TruAlt Bioenergy Limited reported revenue of ₹17.3B in FY2026 versus ₹7.0B in FY2022, a compound +25.5%/yr. Reported net income was ₹969M in FY2026, compounding +26.7%/yr from FY2022.
Is TRUALT fairly valued? → Check now
Similar stocks
6 more Oil & Gas Refining & Marketing stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Reliance Industries Limited RELIANCE | ₹1,259 | ₹835.66 | -34% |
| Marathon Petroleum Corporation MPC | $263.28 | $114.61 | -56% |
| Valero Energy Corporation VLO | $257.99 | $109.18 | -58% |
| Phillips 66 PSX | $168.41 | $61.46 | -64% |
| Neste Oyj NESTE | €28.45 | €6.38 | -78% |
| ENEOS Holdings JXHLY | $16.46 | $17.72 | +8% |
Explore undervalued stocks
More undervalued Energy stocks →
Frequently asked questions
Is TruAlt Bioenergy Limited (TRUALT) undervalued?
What is the fair value of TRUALT?
What is the quality score of TRUALT?
What is the revenue of TruAlt Bioenergy Limited (TRUALT)?
What is the net profit margin of TRUALT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.